Literature DB >> 10604143

Hypoglycinaemia and psychomotor delay in a child with xeroderma pigmentosum.

E J Quackenbush1, K H Kraemer, W A Gahl, V Schirch, D A Whiteman, K Levine, H L Levy.   

Abstract

Glycine is a nonessential amino acid that serves as both an inhibitory and an excitatory neurotransmitter. Hyperglycinaemia occurs in non-ketotic hyperglycinaemia, a primary defect in the glycine cleavage pathway, and as a secondary feature of several inborn errors of organic acid metabolism. However, specifically low levels of glycine have never been reported. Here we report a child with complementation group C xeroderma pigmentosum (XP) characterized by a splice donor mutation in the XPC gene, multiple skin cancers and specific and persistent hypoglycinaemia. He has cognitive delay, lack of speech, autistic features, hyperactivity and hypotonia, all unexplained by the diagnosis of XP group C, a non-neurological form of the disease. Treatment with oral glycine has improved his hyperactivity. Specific hypoglycinaemia could indicate a metabolic disorder producing neurological dysfunction. Whether it is related to or coincidental with the XP is unclear.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604143     DOI: 10.1023/a:1005691424004

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  Quantitative metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry: comparison of isolation methods.

Authors:  J A Thompson; S P Markey
Journal:  Anal Chem       Date:  1975-07       Impact factor: 6.986

2.  Molecular cloning, characterization, and regulation of the human mitochondrial serine hydroxymethyltransferase gene.

Authors:  P J Stover; L H Chen; J R Suh; D M Stover; K Keyomarsi; B Shane
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

Review 3.  The role of glutamate in neurotransmission and in neurologic disease.

Authors:  J T Greenamyre
Journal:  Arch Neurol       Date:  1986-10

4.  Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration.

Authors:  J H Robbins
Journal:  JAMA       Date:  1988-07-15       Impact factor: 56.272

5.  Clinical and cellular studies of sarcosinemia.

Authors:  C R Scott; S H Clark; C C Teng; K R Swedberg
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

6.  Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry.

Authors:  D H Chace; S L Hillman; D S Millington; S G Kahler; B W Adam; H L Levy
Journal:  Clin Chem       Date:  1996-03       Impact factor: 8.327

7.  Determination of serine hydroxymethyltransferase and reduced folate pools in tissue extracts.

Authors:  D W Kim; S Delle Fratte; S S Jeong; V Schirch
Journal:  Anal Biochem       Date:  1997-11-15       Impact factor: 3.365

8.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

9.  Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.

Authors:  S G Khan; H L Levy; R Legerski; E Quackenbush; J T Reardon; S Emmert; A Sancar; L Li; T D Schneider; J E Cleaver; K H Kraemer
Journal:  J Invest Dermatol       Date:  1998-11       Impact factor: 8.551

10.  Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus.

Authors:  J Hananian; J E Cleaver
Journal:  Clin Genet       Date:  1980-01       Impact factor: 4.438

View more
  7 in total

1.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 2.  XPC: Going where no DNA damage sensor has gone before.

Authors:  Leah Nemzow; Abigail Lubin; Ling Zhang; Feng Gong
Journal:  DNA Repair (Amst)       Date:  2015-09-09

3.  XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Authors:  Sikandar G Khan; Kyu-Seon Oh; Steffen Emmert; Kyoko Imoto; Deborah Tamura; John J Digiovanna; Tala Shahlavi; Najealicka Armstrong; Carl C Baker; Marcy Neuburg; Chris Zalewski; Carmen Brewer; Edythe Wiggs; Raphael Schiffmann; Kenneth H Kraemer
Journal:  DNA Repair (Amst)       Date:  2008-11-14

Review 4.  L-serine in disease and development.

Authors:  Tom J de Koning; Keith Snell; Marinus Duran; Ruud Berger; Bwee-Tien Poll-The; Robert Surtees
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

5.  Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging.

Authors:  Masatoshi Tomi; Yuanzi Zhao; Shanthie Thamotharan; Bo-Chul Shin; Sherin U Devaskar
Journal:  Brain Res       Date:  2012-12-07       Impact factor: 3.252

Review 6.  Guanidinoacetic acid deficiency: a new entity in clinical medicine?

Authors:  Sergej M Ostojic; Laszlo Ratgeber; Andras Olah; Jozsef Betlehem; Pongras Acs
Journal:  Int J Med Sci       Date:  2020-09-12       Impact factor: 3.738

Review 7.  The Role of Amino Acids in Neurotransmission and Fluorescent Tools for Their Detection.

Authors:  Rochelin Dalangin; Anna Kim; Robert E Campbell
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.